PDS Biotechnology

Filed a patent for "non-hla restricted t cell vaccine for tcr gamma alternate reading frame protein (tarp) protein expressing cancers" on Thu, September 26, 2024

Filed a patent for "t cell activating immunotherapeutic for treatment of mucin 1 protein expressing human cancers" on Thu, September 26, 2024

Filed a patent for "recombinant protein vaccines formulated with enantio-specific cationic lipid r-dotap and methods of use thereof" on Thu, September 26, 2024

Filed a patent for "novel hpv16 non hla-restricted t-cell vaccines, compositions and methods of use thereof" on Thu, October 20, 2022

Filed a patent for "novel non-hla restricted t cell vaccine for tcr gamma alternate reading frame protein (tarp) protein expressing cancers" on Mon, October 17, 2022

Filed a patent for "t cell activating immunotherapeutic for treatment of mucin 1 protein expressing human cancers" on Wed, October 19, 2022

Filed a patent for "recombinant protein vaccines formulated with enantio-specific cationic lipid r-dotap induce protective cellular and antibody mediated immune responses in mice" on Fri, October 21, 2022

Filed a patent for "lipids as synthetic vectors to enhance antigen processing and presentation ex-vivo in dendritic cell therapy" on Thu, September 14, 2023

Filed a patent for "recombinant protein vaccines formulated with enantio-specific cationic lipid r-dotap induce protective cellular and antibody mediated immune responses in mice" on Mon, September 18, 2023

Filed a patent for "methods to alter the tumor microenvironment for effective cancer immunotherapy" on Thu, February 16, 2023